Clinical trial Recruiting at 1 site Interventional Ages 40 to 85

fNIRS neurofeedback with motor imagery to improve balance and walking in Parkinson's disease

Official title: The Novel Application of fNIRS-based Neurofeedback to Enhance Effects of Motor Imagery on Balance and Gait Performance in Individuals With Parkinson's Disease

Run by National Yang Ming Chiao Tung University · NCT05800470 · Data updated 2026-11-12

This will see if adding fNIRS-based neurofeedback to motor imagery can improve balance and walking in people with Parkinson's disease.

More Parkinson Disease trials

Quick facts

Study typeInterventional
Ages40 Years to 85 Years
SexAll
Enrollment93 (estimated)
SponsorNational Yang Ming Chiao Tung University
Academic / other
Locations1 site (Taipei, None Selected)
StatusRecruiting
StartedMarch 19, 2025
Main results expectedAugust 1, 2025
Study endsAugust 1, 2025
Registry record updatedAugust 7, 2025
Trial IDNCT05800470 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 40–85 with idiopathic Parkinson's disease (Hoehn and Yahr stage <4), stable medical treatment, able to walk independently for at least 10 minutes, and without major cognitive impairment or very low motor imagery ability.

Probably not a fit

Patients unlikely to benefit include those with significant cognitive impairment (MMSE <24), very low motor imagery ability (KVIQ <25), deep brain stimulation or brain metal implants, other neurological or psychiatric disorders, or who cannot attend in-person sessions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study has two parts: a cross-sectional comparison of motor imagery ability and the effects of fatigue in people with Parkinson's disease versus age-matched healthy controls, and a randomized controlled trial testing interventions in people with Parkinson's. In the RCT, participants are randomly assigned to neurofeedback-plus-motor-imagery, motor-imagery-only, or motor training groups and receive 12 sessions over four weeks. Neurofeedback uses functional near-infrared spectroscopy (fNIRS) during 20-minute motor imagery sessions, followed by balance and gait training, while outcomes (Mini-BEST, TUG, gait measures) are measured before, after, and at follow-up. The cross-sectional part examines general and induced fatigue using validated scales and correlates fatigue levels with motor imagery ability.

Why it matters

Potential benefit: If successful, this approach could improve balance and gait and potentially reduce fall risk in people with Parkinson's disease.

How similar studies have gone: Related neurofeedback and motor imagery studies in Parkinson's have shown promising but preliminary results in small samples, so fNIRS-based neurofeedback for gait and balance remains relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Part 1

Additional Inclusion Criteria for PD:

1. diagnosis of idiopathic PD by neurologist with Hoehn and Yahr stage \< 4;
2. stable medical condition;
3. capability of walking independently without walking devices.

Exclusion Criteria:

1. cognitive impairment indicated by MMSE score \< 24;
2. motor imagery ability indicated by KVIQ score \< 25;
3. unable recognize 26 letters in the English alphabet
4. history of diseases or conditions known to interfere with participating this study (e.g. epilepsy, metal implants in the brain, or deep brain stimulation);
5. diagnosis of any other neurological disease or psychiatric disorder (e.g. stroke, anxiety disorder, or depression);
6. using central nervous system medications other than for PD, e.g. antiepileptic drugs in recent 3 months.

Part 2

Inclusion Criteria:

1. aged 40-85 y/o;
2. diagnosis of idiopathic PD by neurologist with Hoehn and Yahr stage \< 4;
3. stable medical condition;
4. capability of walking independently for 10 minutes, which is the time needed for imagery walking training in order to eliminate the possible influence of physical fatigue.

Exclusion Criteria:

1. cognitive impairment indicated by MMSE score \< 24;
2. history of diseases or conditions known to interfere with participating this study (e.g. epilepsy, metal implants in the brain, or deep brain stimulation);
3. diagnosis of any other neurological disease or psychiatric disorder (e.g. stroke, anxiety disorder, or depression);
4. using central nervous system medications other than for PD, e.g. antiepileptic drugs in recent 3 months.

Where it's running

  • National Yang Ming Chiao Tung University
    Taipei, None Selected, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Ray-Yau Wang — National Yang Ming Chiao Tung University
  • Study coordinator: Ray-Yau Wang
  • Email: rywang@nycu.edu.tw
  • Phone: +88628267210

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.